HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer

Abstract HOX transcript antisense intergenic RNA (HOTAIR) is an oncogenic non-coding RNA whose expression is strongly correlated with the tumor grade and prognosis of a variety of carcinomas including breast cancer (BC). HOTAIR regulates various target genes via sponging and epigenetic mechanisms an...

Full description

Bibliographic Details
Main Authors: Ganji Seeta Rama Raju, Eluri Pavitra, Sai Samyuktha Bandaru, Ganji Lakshmi Varaprasad, Ganji Purnachandra Nagaraju, Rama Rao Malla, Yun Suk Huh, Young-Kyu Han
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Molecular Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12943-023-01765-3
_version_ 1797854008130404352
author Ganji Seeta Rama Raju
Eluri Pavitra
Sai Samyuktha Bandaru
Ganji Lakshmi Varaprasad
Ganji Purnachandra Nagaraju
Rama Rao Malla
Yun Suk Huh
Young-Kyu Han
author_facet Ganji Seeta Rama Raju
Eluri Pavitra
Sai Samyuktha Bandaru
Ganji Lakshmi Varaprasad
Ganji Purnachandra Nagaraju
Rama Rao Malla
Yun Suk Huh
Young-Kyu Han
author_sort Ganji Seeta Rama Raju
collection DOAJ
description Abstract HOX transcript antisense intergenic RNA (HOTAIR) is an oncogenic non-coding RNA whose expression is strongly correlated with the tumor grade and prognosis of a variety of carcinomas including breast cancer (BC). HOTAIR regulates various target genes via sponging and epigenetic mechanisms and controls various oncogenic cellular and signaling mechanisms including metastasis and drug resistance. In BC cells, HOTAIR expression is regulated by a variety of transcriptional and epigenetic mechanisms. In this review, we describe the regulatory mechanisms that govern HOTAIR expression during cancer development and explore how HOTAIR drives BC development, metastasis, and drug resistance. In the final section of this review, we focus on the role of HOTAIR in BC management, therapeutic treatment, and prognosis, highlighting its potential therapeutic applications.
first_indexed 2024-04-09T19:59:59Z
format Article
id doaj.art-b312d544bb98484e91fc02a03f64f3ae
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-04-09T19:59:59Z
publishDate 2023-03-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-b312d544bb98484e91fc02a03f64f3ae2023-04-03T05:18:48ZengBMCMolecular Cancer1476-45982023-03-0122111510.1186/s12943-023-01765-3HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancerGanji Seeta Rama Raju0Eluri Pavitra1Sai Samyuktha Bandaru2Ganji Lakshmi Varaprasad3Ganji Purnachandra Nagaraju4Rama Rao Malla5Yun Suk Huh6Young-Kyu Han7Department of Energy and Materials Engineering, Dongguk University–SeoulNanoBio High-Tech Materials Research Center, Biological Sciences and Bioengineering, Inha UniversityBaton Rouge General HospitalNanoBio High-Tech Materials Research Center, Biological Sciences and Bioengineering, Inha UniversitySchool of Medicine, Division of Hematology and Oncology, University of AlabamaCancer Biology Laboratory, Department of Biochemistry and Bioinformatics, GIS, GITAM (Deemed to be University)NanoBio High-Tech Materials Research Center, Biological Sciences and Bioengineering, Inha UniversityDepartment of Energy and Materials Engineering, Dongguk University–SeoulAbstract HOX transcript antisense intergenic RNA (HOTAIR) is an oncogenic non-coding RNA whose expression is strongly correlated with the tumor grade and prognosis of a variety of carcinomas including breast cancer (BC). HOTAIR regulates various target genes via sponging and epigenetic mechanisms and controls various oncogenic cellular and signaling mechanisms including metastasis and drug resistance. In BC cells, HOTAIR expression is regulated by a variety of transcriptional and epigenetic mechanisms. In this review, we describe the regulatory mechanisms that govern HOTAIR expression during cancer development and explore how HOTAIR drives BC development, metastasis, and drug resistance. In the final section of this review, we focus on the role of HOTAIR in BC management, therapeutic treatment, and prognosis, highlighting its potential therapeutic applications.https://doi.org/10.1186/s12943-023-01765-3Breast cancerDrug resistanceHOTAIRMetastasisPrognosis
spellingShingle Ganji Seeta Rama Raju
Eluri Pavitra
Sai Samyuktha Bandaru
Ganji Lakshmi Varaprasad
Ganji Purnachandra Nagaraju
Rama Rao Malla
Yun Suk Huh
Young-Kyu Han
HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer
Molecular Cancer
Breast cancer
Drug resistance
HOTAIR
Metastasis
Prognosis
title HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer
title_full HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer
title_fullStr HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer
title_full_unstemmed HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer
title_short HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer
title_sort hotair a potential metastatic drug resistant and prognostic regulator of breast cancer
topic Breast cancer
Drug resistance
HOTAIR
Metastasis
Prognosis
url https://doi.org/10.1186/s12943-023-01765-3
work_keys_str_mv AT ganjiseetaramaraju hotairapotentialmetastaticdrugresistantandprognosticregulatorofbreastcancer
AT eluripavitra hotairapotentialmetastaticdrugresistantandprognosticregulatorofbreastcancer
AT saisamyukthabandaru hotairapotentialmetastaticdrugresistantandprognosticregulatorofbreastcancer
AT ganjilakshmivaraprasad hotairapotentialmetastaticdrugresistantandprognosticregulatorofbreastcancer
AT ganjipurnachandranagaraju hotairapotentialmetastaticdrugresistantandprognosticregulatorofbreastcancer
AT ramaraomalla hotairapotentialmetastaticdrugresistantandprognosticregulatorofbreastcancer
AT yunsukhuh hotairapotentialmetastaticdrugresistantandprognosticregulatorofbreastcancer
AT youngkyuhan hotairapotentialmetastaticdrugresistantandprognosticregulatorofbreastcancer